Growth hormone treatment induces mammary gland hyperplasia in aging primates

Nature Medicine

Volumn 3, Issue 10, 1997, Pages 1141-1144

  Ng, Siu T ^a   Zhou, Jian ^a   Adesanya, Oluyemisi O ^a   Wang, Jie ^a   LeRoith, Derek ^b   Bondy, Carolyn A ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN C;

AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST EPITHELIUM; BREAST HYPERPLASIA; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; FEMALE; GROWTH HORMONE DEFICIENCY; GYNECOMASTIA; HORMONE ACTION; MITOGENESIS; NONHUMAN; PRIORITY JOURNAL; RHESUS MONKEY;

AGING; ANIMALS; CELL DIVISION; EPITHELIAL CELLS; FEMALE; GROWTH HORMONE; HUMANS; HYPERPLASIA; INSULIN-LIKE GROWTH FACTOR I; KI-67 ANTIGEN; MACACA MULATTA; MAMMARY GLANDS, ANIMAL; MITOTIC INDEX; RECEPTORS, PROLACTIN; RECEPTORS, SOMATOTROPIN; REGRESSION ANALYSIS;

EID: 0030819823     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm1097-1141     Document Type: Article

References (23)

1. Rudman, D. et al. Effects of human growth hormone in men over 60 years old. N. Engl. J. Med. 323, 1-6 (1990).
2. Forsyth, I.A. The mammary gland. Baillieres Clin. Endocrinol. Metab. 5, 809-832 (1991).
3. Kleinberg, D.L., Ruan, W., Catanese, V., Newman, C.B. & Feldman, M. Non-lactogenic effects of growth hormone on growth and insulin-like growth factor-I messenger ribonucleic acid of rat mammary gland. Endocrinology 126, 3274-3276 (1990).
4. Plaut, K., Ikeda, M. & Vonderhaar, B.K. Role of growth hormone and insulin-like growth factor-I in mammary development. Endocrinology 133, 1843-1848 (1993).
5. Kleinberg, D.L. et al. Primate mammary development: Effects of hypophysectomy, prolactin inhibition, and growth hormone administration. J. Clin. Invest. 75, 1943-1950 (1985).
6. Malozowski, S. & Stadel, B.V. Prepubertal gynecomastia during growth hormone therapy. J. Pediatr. 126, 659-661 (1995).
7. Hunter, D.J. & Willett, W.C. Diet, body size, and breast cancer. Epidemiol. Rev. 15, 110-132 (1993).
8. Nabarro, J.D. Acromegaly. Clin. Endocrinol. (Oxf) 26, 481-512 (1987).
9. LeRoith, D. et al. The effects of growth hormone and insulin-like growth factor I on the immune system of aged female monkeys. Endocrinology 137, 1071-1079 (1996).
10. Gerdes, J., Schwab, U., Lemke, H. & Stein, H. Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int. J. Cancer 31, 13-20 (1983).
11. Kelly, P.A. et al. The growth hormone/prolactin receptor family. Recent Prog. Horm. Res. 48, 123-164 (1993).
12. Djiane, J., Houdebine, L.M. & Kelly, P.A. Prolactin-like activity of anti-prolactin receptor antibodies on casein and DNA synthesis in the mammary gland. Proc. Natl. Acad. Sci. USA 78, 7445-7448 (1981).
13. Fuh, G. & Wells, J.A. Prolactin receptor antagonists that inhibit the growth of breast cancer cell lines. J. Biol. Chem. 270, 13133-13137 (1995).
14. Martinez, A.J. Prolactin and carcinoma of the breast. Mayo Clin. Proc. 67, 1011-1012 (1992).
15. Bondy, C.A. et al. Clinical uses of insulin-like growth factor-I. Ann. Intern. Med. 120, 593-601 (1994).
16. Yee, D. et al. Analysis of insulin-like growth factor I gene expression in malignancy: Evidence for a paracrine role in human breast cancer. Mol. Endocrinol. 3, 509-517 (1989).
17. Neuenschwander, S. et al. Involution of the lactating mammary gland is inhibited by the IGF system in a transgenic mouse model. J. Clin. Invest. 97, 2225-2232 (1996).
18. Hadsell, D.L., Greenberg, N.M., Fligger, J.M., Baumrucker, C.R. & Rosen, J.M. Targeted expression of des(1-3) human insulin-like growth factor I in transgenic mice influences mammary gland development and IGF-binding protein expression. Endocrinology 137, 321-330 (1996).
19. Adesanya, O.O., Zhou, J. & Bondy, C.A. Sex steroid regulation of insulin-like growth factor system gene expression and proliferation in primate myometrium. J. Clin. Endocrinol. Metab. 81, 1967-1974 (1996).
20. Lee, A.V. & Yee, D. Insulin-like growth factors and breast cancer. Biomed. Pharmacother. 49, 415-421 (1995).
21. Baum, H.B. et al. Effects of physiologic growth hormone therapy on bone density and body composition in patients with adult-onset growth hormone deficiency. Ann. Intern. Med. 125, 883-890 (1996).
22. Toogood, A.A., Adams, J.E., O'Neill, P.A. & Shalet, S.M. Elderly patients with adult-onset growth hormone deficiency are not osteopenic. J. Clin. Endocrinol. Metab. 82, 1462-1466 (1997).
23. Mulligan, K., Grunfeld, C., Hellerstein, M.K., Neese, R.A. & Schambelan, M. Anabolic effects of recombinant human growth hormone in patients with wasting associated with human immunodeficiency virus infection. J. Clin. Endocrinol. Metab. 77, 956-962 (1993).